100m Russia Covid doses for India
The Telegraph India, | New Delhi | G.S. Mudur 17.09.20, 02:11 AM “The phase 1 and phase 2 results have shown promise. We will be conducting phase 3 trials in India to meet the requirements of Indian regulators,” DRL managing director G.V. Prasad said in the statement. Vaccine researchers say a clinical trial in India, if approved by the regulatory authority, would likely involve a few thousand healthy volunteers. The proposal to distribute 100 million doses is intended to support a mass vaccination campaign, the researchers said. “They are meant for population-wide general use — a mass vaccination campaign,” a spokesperson for the RDIF told The Telegraph, adding that an application for the clinical trials in India would be filed soon. The application will need to be filed with the Central Drugs Standard Control Organisation (CDSCO), India’s regulatory authority for drugs and vaccines. Under standard procedures, any mass ...